Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.
about
An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsAlkyne-azide "click" chemistry in designing nanocarriers for applications in biologyDesign and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondriaVitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic miceCombination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.Isoprenoids, small GTPases and Alzheimer's disease.The plasma membrane redox system is impaired by amyloid β-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice.Neuroprotective strategies involving ROS in Alzheimer disease.Coenzyme Q10 and cognition in atorvastatin treated dogs.The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeuticsCoenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice.Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.Microglial Inhibitory Mechanism of Coenzyme Q10 Against Aβ (1-42) Induced Cognitive Dysfunctions: Possible Behavioral, Biochemical, Cellular, and Histopathological Alterations.Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbersAntioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?Coenzyme Q10 effects in neurodegenerative disease.Mitochondria: a therapeutic target in neurodegenerationMitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid betaMitochondrial medicine for neurodegenerative diseases.An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders.Oxidant/Antioxidant imbalance and the risk of Alzheimer's diseaseMitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q(10) ?Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal.Increased phosphorylation of tau and synaptic protein loss in the aged transgenic mice expressing familiar Alzheimer's disease-linked presenilin 1 mutation.Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis.
P2860
Q26751302-3E7A783F-33C3-4ED5-8D78-155E23437040Q26995503-FE10695C-7E9A-479C-A744-1AE50733435AQ28830013-2D79A5DD-F693-4E09-8E2C-CF2731BAF320Q33688727-6FED82FD-AAE3-4DF3-A10F-E8F31A766BB2Q33837238-00FAB1FF-9A18-41D7-A431-1021F5398F4DQ33915441-E1F7C5FC-9F05-41F1-8DD8-8DF41BF846A7Q34159225-5A20E81A-324B-431F-882A-DE2FB82CB202Q34757939-3F3A1A8A-81AE-4CDD-8944-2EFC5B522271Q35215658-A0750185-7FDA-4FAB-A1B8-FE9E46F76E92Q35216140-EB35ADFD-3D42-4B14-87C5-08889D695FE8Q35706496-5AA7F31B-92B1-406F-B9B1-4067669BC16FQ35756089-57E39839-7687-41DE-A532-7CB6C212FD92Q35916588-7121DAAC-8AD2-4B14-9328-D9A50382E201Q36260932-BC7730AD-B97F-415C-8FCF-C0AC37FCD0B9Q36799584-B5486491-7300-4C0E-A6DC-FDBDD9BB7E07Q36866566-BF0E96D5-5626-4C90-922B-B21FF86EBE9BQ37441183-64272A59-063D-4A37-9663-418C19843B60Q37448888-13D1EBE2-CC70-4B5A-BD4F-1546931AD7D4Q37466059-5214F39C-F3BF-47C3-B92D-DB0E862B2B74Q37555305-E3EAD0C7-B6CB-4D22-B074-6268CFB7AF47Q37672741-BA0F55E2-A794-4034-8F2C-9351F00590B3Q37733587-BC0F6FEA-857D-4DAF-B8DD-B3FB84F8CD35Q37741560-16969842-57E8-44A8-9EDB-9A24F93BBB1BQ37947197-A00F4DDA-F510-47AB-8440-619DEF7DC847Q38253060-D1105CDB-6FA1-46BF-BC35-A57FDCEE2782Q41553884-ED54E5A8-A1ED-406C-9A13-439372D8A48DQ44546858-EFF85443-2D6E-434B-9B8D-E82D844A224CQ46078160-9572366E-BD53-4697-89DC-E33C58056267
P2860
Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Coenzyme Q10 attenuates beta-a ...... zheimer presenilin 1 mutation.
@en
Coenzyme Q10 attenuates beta-a ...... zheimer presenilin 1 mutation.
@nl
type
label
Coenzyme Q10 attenuates beta-a ...... zheimer presenilin 1 mutation.
@en
Coenzyme Q10 attenuates beta-a ...... zheimer presenilin 1 mutation.
@nl
prefLabel
Coenzyme Q10 attenuates beta-a ...... zheimer presenilin 1 mutation.
@en
Coenzyme Q10 attenuates beta-a ...... zheimer presenilin 1 mutation.
@nl
P2093
P2860
P921
P1476
Coenzyme Q10 attenuates beta-a ...... zheimer presenilin 1 mutation.
@en
P2093
Edward S Yang
Jianzhi Wang
Xifei Yang
P2860
P2888
P304
P356
10.1007/S12031-007-9033-7
P577
2008-01-05T00:00:00Z